Trial name


Trial Summary




Myeloma 12 (ACCORD)


This trial is for people who have had a stem cell transplant and who had no sign of their myeloma (in remission) for at least 12 months before it came back. The people taking part must be fit and healthy enough to have another stem cell transplant.





This trial is looking at treating newly diagnosed solitary bone plasmacytoma with lenalidomide and dexamethasone after having radiotherapy.





This is a study looking to treat people with myeloma who have had between 2-4 lines of treatment in the past, including lenalidomide. It will look at the effects of melflufan and dexamethasone vs pomalidomide and dexamethasone.





A trial for people with high risk multiple myeloma, looking at a novel combination of several anti-cancer drugs